Cargando…
Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice?
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540258/ https://www.ncbi.nlm.nih.gov/pubmed/35796147 http://dx.doi.org/10.1111/dth.15697 |
| _version_ | 1784803672013668352 |
|---|---|
| author | Mastorino, Luca Roccuzzo, Gabriele Dapavo, Paolo Siliquini, Niccolò Avallone, Gianluca Rubatto, Marco Quaglino, Pietro Ribero, Simone |
| author_facet | Mastorino, Luca Roccuzzo, Gabriele Dapavo, Paolo Siliquini, Niccolò Avallone, Gianluca Rubatto, Marco Quaglino, Pietro Ribero, Simone |
| author_sort | Mastorino, Luca |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9540258 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley & Sons, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95402582022-10-14 Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice? Mastorino, Luca Roccuzzo, Gabriele Dapavo, Paolo Siliquini, Niccolò Avallone, Gianluca Rubatto, Marco Quaglino, Pietro Ribero, Simone Dermatol Ther Letters John Wiley & Sons, Inc. 2022-07-19 2022-09 /pmc/articles/PMC9540258/ /pubmed/35796147 http://dx.doi.org/10.1111/dth.15697 Text en © 2022 The Authors. Dermatologic Therapy published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters Mastorino, Luca Roccuzzo, Gabriele Dapavo, Paolo Siliquini, Niccolò Avallone, Gianluca Rubatto, Marco Quaglino, Pietro Ribero, Simone Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice? |
| title | Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice? |
| title_full | Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice? |
| title_fullStr | Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice? |
| title_full_unstemmed | Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice? |
| title_short | Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice? |
| title_sort | switching from il23 inhibitors to il17 inhibitors: a safe and effective practice? |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540258/ https://www.ncbi.nlm.nih.gov/pubmed/35796147 http://dx.doi.org/10.1111/dth.15697 |
| work_keys_str_mv | AT mastorinoluca switchingfromil23inhibitorstoil17inhibitorsasafeandeffectivepractice AT roccuzzogabriele switchingfromil23inhibitorstoil17inhibitorsasafeandeffectivepractice AT dapavopaolo switchingfromil23inhibitorstoil17inhibitorsasafeandeffectivepractice AT siliquininiccolo switchingfromil23inhibitorstoil17inhibitorsasafeandeffectivepractice AT avallonegianluca switchingfromil23inhibitorstoil17inhibitorsasafeandeffectivepractice AT rubattomarco switchingfromil23inhibitorstoil17inhibitorsasafeandeffectivepractice AT quaglinopietro switchingfromil23inhibitorstoil17inhibitorsasafeandeffectivepractice AT riberosimone switchingfromil23inhibitorstoil17inhibitorsasafeandeffectivepractice |